Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
city
~8 mi. (Auburn, Washington, +825 more cities)
facility
MultiCare Auburn Medical Center
biomarker
AKT1 Mutation, +91 more biomarkers
condition
Breast Carcinoma, +3 more conditions
drug
adavosertib, +26 more drugs
drug type
immunotherapy, +1 more type
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
city
~8 mi. (Auburn, Washington, +100 more cities)
facility
MultiCare Regional Cancer Center - Auburn
condition
Fallopian Tube Adenocarcinoma, +14 more conditions
drug
carboplatin, +2 more drugs
drug type
chemotherapy, +1 more type
A Phase 3 Efficacy, Safety and Tolerability Study of Zolbetuximab (Experimental Drug) Plus mFOLFOX6 Chemotherapy Compared to Placebo Plus mFOLFOX6 as Treatment for Gastric and Gastroesophageal Junction (GEJ) Cancer
city
~8 mi. (Auburn, Washington, +202 more cities)
facility
MultiCare Regional Cancer Center - Gig Harbor
biomarker
CLDN18 Expression, +1 more biomarker
drug
modified FOLFOX6 regimen, +1 more drug
drug type
chemotherapy, +1 more type
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
city
~8 mi. (Auburn, Washington, +822 more cities)
facility
MultiCare Auburn Medical Center
biomarker
ER Negative, +2 more biomarkers
drug
carboplatin, +3 more drugs
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
city
~8 mi. (Auburn, Washington, +954 more cities)
facility
MultiCare Auburn Medical Center
drug
crizotinib, +4 more drugs
drug type
chemotherapy, +2 more types
A Randomized Study of Olaparib or Placebo in Patients With Surgically Removed Pancreatic Cancer Who Have a BRCA1, BRCA2 or PALB2 Mutation, The APOLLO Trial
city
~8 mi. (Auburn, Washington, +201 more cities)
facility
MultiCare Auburn Medical Center
biomarker
BRCA1 Loss, +5 more biomarkers